335 related articles for article (PubMed ID: 31699796)
1. Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.
Li XY; Moesta AK; Xiao C; Nakamura K; Casey M; Zhang H; Madore J; Lepletier A; Aguilera AR; Sundarrajan A; Jacoberger-Foissac C; Wong C; Dela Cruz T; Welch M; Lerner AG; Spatola BN; Soros VB; Corbin J; Anderson AC; Effern M; Hölzel M; Robson SC; Johnston RL; Waddell N; Smith C; Bald T; Geetha N; Beers C; Teng MWL; Smyth MJ
Cancer Discov; 2019 Dec; 9(12):1754-1773. PubMed ID: 31699796
[TBL] [Abstract][Full Text] [Related]
2. Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
Yan J; Li XY; Roman Aguilera A; Xiao C; Jacoberger-Foissac C; Nowlan B; Robson SC; Beers C; Moesta AK; Geetha N; Teng MWL; Smyth MJ
Cancer Immunol Res; 2020 Mar; 8(3):356-367. PubMed ID: 31992567
[TBL] [Abstract][Full Text] [Related]
3. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
6. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets.
Cortés-Garcia JD; López-López C; Cortez-Espinosa N; García-Hernández MH; Guzmán-Flores JM; Layseca-Espinosa E; Portales-Cervantes L; Portales-Pérez DP
Immunobiology; 2016 Jan; 221(1):84-93. PubMed ID: 26307000
[TBL] [Abstract][Full Text] [Related]
8. Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma.
Sun T; Li Y; Yang Y; Liu B; Cao Y; Yang W
Cell Death Dis; 2022 Oct; 13(10):875. PubMed ID: 36245000
[TBL] [Abstract][Full Text] [Related]
9. eATP/P2X7R Axis: An Orchestrated Pathway Triggering Inflammasome Activation in Muscle Diseases.
Panicucci C; Raffaghello L; Bruzzone S; Baratto S; Principi E; Minetti C; Gazzerro E; Bruno C
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825102
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39) involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus).
Li S; Chen X; Wang N; Li J; Feng Y; Sun J
Mol Immunol; 2019 Aug; 112():10-21. PubMed ID: 31075558
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
13. Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism.
Spatola BN; Lerner AG; Wong C; Dela Cruz T; Welch M; Fung W; Kovalenko M; Losenkova K; Yegutkin GG; Beers C; Corbin J; Soros VB
MAbs; 2020; 12(1):1838036. PubMed ID: 33146056
[TBL] [Abstract][Full Text] [Related]
14. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Aldi S; Marino A; Tomita K; Corti F; Anand R; Olson KE; Marcus AJ; Levi R
FASEB J; 2015 Jan; 29(1):61-9. PubMed ID: 25318477
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.
Casey M; Segawa K; Law SC; Sabdia MB; Nowlan B; Salik B; Lee C; Winterford C; Pearson S; Madore J; Dougall WC; Gandhi MK; Nakamura K
Leukemia; 2023 Feb; 37(2):379-387. PubMed ID: 36539557
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System.
Wu L; Xie W; Li Y; Ni Q; Timashev P; Lyu M; Xia L; Zhang Y; Liu L; Yuan Y; Liang XJ; Zhang Q
Adv Sci (Weinh); 2022 Jun; 9(17):e2105376. PubMed ID: 35396800
[TBL] [Abstract][Full Text] [Related]
17. Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP.
Gao YD; Cao J; Li P; Huang G; Yang J
J Asthma; 2014 Dec; 51(10):997-1003. PubMed ID: 25272186
[TBL] [Abstract][Full Text] [Related]
18. Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice.
Li P; Cao J; Chen Y; Wang W; Yang J
Int J Mol Med; 2014 Jul; 34(1):269-75. PubMed ID: 24804736
[TBL] [Abstract][Full Text] [Related]
19. CD39-adenosinergic axis in renal pathophysiology and therapeutics.
Kishore BK; Robson SC; Dwyer KM
Purinergic Signal; 2018 Jun; 14(2):109-120. PubMed ID: 29332180
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor-Mediated Activation of CD39 Internalization in BMDCs Leads to Extracellular ATP Accumulation and Facilitates P2X7 Receptor Activation.
Zhao R; Qiao J; Zhang X; Zhao Y; Meng X; Sun D; Peng X
Front Immunol; 2019; 10():2524. PubMed ID: 31736956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
